浓缩抗体溶液中静电作用与黏度密切相关
Electrostatics and viscosity are strongly linked in concentrated antibody solutions
AI总结:
该研究通过分子动力学模拟考察高浓度抗体溶液,发现隐式屏蔽库仑模型无法解释黏度上升,显式处理带电结构域、离子及长程静电可揭示瞬态强关联机制。
摘要:
单克隆抗体是现代医学中最具前景的治疗药物之一,但将其制成用于皮下自我给药的高浓度溶液构成了一项重大挑战。一个关键障碍是在这些条件下经常观察到的黏度显著增加。为了更深入地理解这一现象,源自软物质物理学的粗粒化模型已被广泛采用。然而,这些模型尚未被充分用于分析此类体系的流变学集体性质。在本研究中,我们利用分子动力学模拟,从常用模型出发直接计算抗体溶液的黏度;在这些模型中,静电相互作用通过有效的屏蔽库仑势来处理。我们证明该方法无法重现实验证据,并通过分析体系中的应力相关性表明,必须显式处理非均匀带电结构域,同时纳入反离子和盐离子,并恰当考虑库仑相互作用的长程性质。通过彻底分析体系的微观结构,我们进一步揭示了瞬态强关联抗体的存在;若以隐式方式处理电荷,这些抗体便不会出现,从而表明静电作用在决定高浓度下黏度增加方面具有突出作用。利用我们这种贴近真实的处理方式,可以设计新的途径,以确保抗体溶液在预期的广泛使用和有效部署中表现出所需特性。
英文摘要:
Monoclonal antibodies are among the most promising therapeutic agents in modern medicine, yet their formulation into high-concentration solutions for subcutaneous self-administration poses a major challenge. A key obstacle is the marked increase in viscosity often observed under these conditions. To gain deeper insights into this phenomenon, coarse-grained models derived from soft matter physics have been widely employed. However, these models have yet to be fully leveraged for analyzing the rheological collective properties of such systems. In this study, using molecular dynamics simulations, we directly compute the antibody solution viscosity by starting from commonly used models in which electrostatic interactions are treated through effective screened Coulomb potentials. We demonstrate that this approach fails to reproduce experimental evidence and we show, by analyzing stress correlations in the system, that it is necessary to treat the heterogeneously charged domains explicitly, also including counterions and salt ions, and to properly account for the long-ranged nature of Coulomb interactions. By thoroughly analyzing the microscopic structure of the system, we further reveal the presence of transient strongly correlated antibodies which would not be present if charges were treated implicitly, thus pointing to a prominent role of electrostatics in determining the increase in viscosity at high concentrations. By taking advantage of our realistic treatment, new approaches can be devised to ensure that antibody solutions exhibit the desired characteristics for their intended broad use and effective deployment.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。